Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersPediatrics Physician in Halethorpe, MD
NPI: 1427270313Primary Employer
Ozlem Goker-Alpan MD LLC
ldrtc.org
HQ Phone
Get M.D. Ozlem's Phone Numberphone_androidMobile
Get M.D. Ozlem's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 16 | 24 |
| 2 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | 20 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 14 | 21 |
| 4 | 87426Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 14 | 34 |
| 5 | 94016Physician interpretation and report of measurement and graphic recording of amount and speed of breathed air over 30-day period | 13 | 17 |
A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies.
Authors: John Bernat, Eric Wallace, David Warnock
Publication Date: 2024-02-23
Authors: Peter Chang, Suma Shankar, Raphael Schiffmann, Nicola Longo
Journal: Drug Des Devel Ther
Publication Date: 2016-05-25
Lead Sponsor: Sangamo Therapeutics
Intervention / Treatment: BIOLOGICAL: ST-920
Lead Sponsor: Cyclo Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Hydroxypropyl-beta-cyclodextrin
Lead Sponsor: Takeda
Intervention / Treatment: OTHER: Standard of Care